Skip to content
Screener

Black Diamond Therapeutics, Inc. BDTX Q2 2026 earnings

Reported August 5, 2026 · After market close

EPS-$0.17Beat by $0.03
Revenue estimate$5.6M
EPS estimate-$0.20

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$8.3M
EPS estimate-$0.06

FAQ

When did Black Diamond Therapeutics, Inc. report Q2 2026 earnings?
Black Diamond Therapeutics, Inc. (BDTX) reported Q2 2026 earnings on August 5, 2026 after market close.
What were Black Diamond Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Black Diamond Therapeutics, Inc. reported eps of $-0.17 for Q2 2026.
Did Black Diamond Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.20 by $0.03.
How did Black Diamond Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 10.5% from $-0.19.
Where can I find Black Diamond Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001701541-26-000023) and the 10-Q periodic report (0001701541-26-000025) directly on SEC EDGAR. The filing index links above go to sec.gov.